NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Institute for Follicular Lymphoma Innovation

Institute for Follicular Lymphoma Innovation

Diamond Bar, Californiai-fli.org

Overview

Institute for Follicular Lymphoma Innovation is a global, non-profit, private foundation that deploys its budget across grants, project-based partnerships, and venture philanthropy investments to accelerate the development of innovative treatment options for patients with follicular lymphoma.

Year Founded

2022

Portfolio Companies

4

Website

i-fli.org

Investments

Institute for Follicular Lymphoma Innovation investments
CompanyDateStageLead
NanoCell TherapeuticsJun 2025SeedCo-investor
EnteromeJun 2025VC RoundLead
LTZ TherapeuticsApr 2025Series A ExtensionCo-investor
PeproMene BioDec 2024Corporate FundingLead
EnteromeJun 2024VC RoundLead

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersDiamond Bar, California
Year Founded2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.